← Back to the idea

SLC25A45 Carnitine-Pathway Panel for GLP-1RA Response Prediction

A blood test measuring plasma trimethyllysine, carnitine levels, and SLC25A45 genotype to predict whether a patient on GLP-1 receptor agonist therapy will achieve full fat-loss benefit, and to guide carnitine supplementation for non-responders.